Join us on November 7 from 10 AM–3 PM to tour our Frisco clinic, see our treatment spaces and learn more about the services available at Wholesome Clinic, including Spravato treatment for eligible patients.
Finding relief when traditional antidepressants haven’t worked is difficult. Experience a new path forward with supervised Spravato (esketamine) nasal spray therapy, administered at our REMS-certified Frisco, TX clinic. You’ll be in a comfortable, supervised clinical setting dedicated to your progress. Spravato treatment begins with an evaluation. Treatment is not started automatically, and eligibility is determined by a licensed provider after reviewing your diagnosis, prior antidepressant history, current symptoms, safety considerations, and insurance requirements.
Spravato (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression (when symptoms have not improved after trying at least two antidepressants). Under current FDA labeling, it may be used on its own (monotherapy) or together with an oral antidepressant, depending on the patient's treatment plan and clinical needs.
Spravato may be appropriate for adults who:
Spravato treatment is provided in-person at our Frisco, TX clinic and starts with an initial evaluation to confirm fit and next steps.
At Wholesome Clinic, Spravato treatment is structured, supervised, and personalized—from your initial evaluation through ongoing maintenance planning.
We complete a diagnostic assessment, review your treatment history (including prior antidepressant trials), and confirm whether Spravato is an appropriate option for you.
Our team supports the administrative steps, which may include insurance verification, prior authorization, required documentation, and REMS program requirements.
Treatment begins with a supervised in-office session. You self-administer the nasal spray, followed by at least two hours of monitoring for safety and tolerability.
During induction, we monitor symptoms, side effects, and overall functioning at each visit. Response and timing vary by patient.
We continue tracking progress and adjust the plan as clinically appropriate, based on your response and tolerability.
Maintenance frequency is individualized (for example, weekly, every other week, or monthly), depending on clinical response and your treatment plan.
We track outcomes, address side effects, and coordinate next steps as part of your broader mental health care plan.
If you’ve tried antidepressants without enough improvement, you’re not alone. A Spravato evaluation can help determine whether this treatment is a good fit and what to expect.
Schedule Your EvaluationThese are common preparation steps. Your clinician will confirm what applies to you based on your medical history and treatment plan.
Because Spravato can cause temporary sedation, dizziness, dissociation, or changes in alertness, patients cannot drive after treatment. A safe ride home is required after each Spravato session. Eligible patients may have access to limited local transportation support, depending on distance, availability, and clinical discretion.
Coordinated Care: Transportation assistance may be arranged for eligible patients within a 10-mile radius, including support for both arrival and a safe return home following treatment. Designed to prioritize safety and ease.
Safe Return: For patients outside the immediate area, transportation support may be available for return trips home following treatment. Options are coordinated based on distance, availability, and clinical considerations.
Staff Coordinated: Transportation is arranged through secure, healthcare-compliant services. Our team ensures a smooth transition from your appointment to your ride for a safe and supported experience.
This quick self-check can help you decide whether a Spravato/TRD evaluation may be worth scheduling. It does not diagnose depression or determine eligibility. Final recommendations are made after a clinical evaluation.
Disclaimer: This quiz is for educational purposes only and does not diagnose or determine eligibility. A licensed clinician will make the final determination.
Quick answers to common questions about eligibility, monitoring requirements, side effects, and logistics. A clinician will review your history and confirm whether Spravato is appropriate for you.
Our team can help you understand next steps, scheduling requirements, and the insurance authorization process.
Contact Our Team
Stephanie Ukoha provides comprehensive Spravato® (esketamine) evaluations for patients in Frisco, TX, and surrounding North Texas communities. She specializes in the assessment and treatment of treatment-resistant depression and carefully reviews each patient's mental health history, prior medication trials, current symptoms, and medical background to determine whether Spravato may be an appropriate treatment option. Her approach emphasizes safety, evidence-based care, and personalized treatment planning tailored to each patient's unique needs.
If you’re exploring whether Spravato may be appropriate, our team will guide you through eligibility screening, insurance authorization, REMS requirements, and monitored in-clinic sessions.
Ready to take the next step?
Prefer to send a message? Contact our team online.
